March 22 (Reuters) - Roche Holding AG ROG.S :
* HEALTH CANADA APPROVES RITUXAN® SUBCUTANEOUS FORMULATION FOR CANADIANS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
* HOFFMANN-LA ROCHE - HEALTH CANADA APPROVES RITUXAN SC FORMULATION FOR CANADIANS WITH CHRONIC LYMPHOCYTIC LEUKEMIA